Short answer
Lifevantage Corp (LFVN) filed its Q4 2025 10-Q quarterly report on Feb 4, 2026 for the quarter ended Dec 31, 2025. Quarterly revenue was $49M (down 27.8% year over year) with net income of $276,000.
Q4 2025 key financials · XBRL
- Revenue
- $49M
- −27.8% YoY · +2.9% QoQ
- Net income
- $276,000
- −89.2% YoY · −87.2% QoQ
- Operating margin
- 1.0%
- Gross margin
- 74.0%
- EPS (diluted)
- $0.02
- −90.0% YoY · −88.2% QoQ
Source: XBRL data from the Lifevantage Corp (LFVN) Q4 2025 10-Q on SEC EDGAR. USD.
Lifevantage Corp Q4 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No newly added risk factors this quarter; no material changes from most recent 10-K
- Continued risk of regulatory compliance impacting business due to multi-level marketing laws and FDA regulations
- Operational risk from dependence on independent distributors for product sales and market expansion
- Market risk from competitive dietary supplement industry with rapid product innovation and pricing pressure
- Financial risk related to liquidity maintenance amid cash flow variability from distributor commission cycles
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Lifevantage Corp quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.